EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion

Alessandro Invernizzi iD, Matteo Airaldi iD, Mariano Cozzi iD, Vuong Nguyen iD, Yohei Hashimoto, Daniel Barthelmes, Louise O'Toole, Theodorus Leonardus Ponsioen, Pavol Kusenda, Francisco Javier Lavid, Nandor Jaross, Mark Gillies und 1 weitere

Clinical & Experimental Ophthalmology · 2025

DOI: 10.1111/ceo.14468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2025. Verfasst von Alessandro Invernizzi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Angiogenesis Inhibitors, Macular Edema, Cataract Extraction. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Royal Australian and New Zealand College of Ophthalmologists Eye Foundation, National Health and Medical Research Council, Unrestricted educational grants from Bayer (Leverkusen, Germany) and Novartis (Basel, Switzerland).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess clinical outcomes of cataract surgery in eyes treated with intravitreal injections for cystoid macular oedema (CMO) secondary to retinal vein occlusions (RVOs).

Methods

Eyes receiving intravitreal injections for CMO secondary to RVOs that underwent cataract extraction were identified from the Fight Retinal Blindness! Registry and matched 1:1 by 9 parameters with phakic controls also receiving intravitreal injections for the same condition. VA change at 12 months, central subfield thickness (CST) and injection frequency before and after surgery were compared between the two groups. The effect of baseline features on the final VA including age, CST, treatment frequency among others was tested.

Results

We included 193 eyes that had cataract extraction (exposed) matched with 193 phakic eyes that did not have surgery (matched). VA (95%CI) changed by +9.9 (7, 12.8) letters in exposed eyes versus −2.4 (−4.1, −0.7) letters in matched eyes ( p < 0.01). The mean [SD] VA at 12 months was similar in exposed and matched eyes [60.7 (23.0) vs. 61.1 (24.3) letters, respectively, p = 0.81]. The mean [SD] CST was similar between groups before and at surgery, but it was greater in exposed compared with matched eyes [353 (152) vs. 322 (123) μm, respectively, p = 0.03] 12 months after surgery. Exposed eyes received more injections [median (range)] than matched eyes during the 12 months after surgery [5 (3, 7) vs. 4 (1, 6), injections, p < 0.01].

Conclusions

Cataract extraction delivered good visual outcomes in patients treated for CMO secondary to RVOs. More injections were required on average in the 12 months after surgery in eyes undergoing surgery compared to matched controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Vein OcclusionAngiogenesis InhibitorsMacular EdemaCataract ExtractionPhacoemulsificationHumansIntravitreal InjectionsVisual AcuityMaleFemaleAgedVascular Endothelial Growth Factor ATomography, Optical CoherenceMiddle AgedRanibizumabRegistriesRetrospective StudiesGlucocorticoidsAged, 80 and overTreatment OutcomeCataract

Stichwörter der Autor:innen

RVOanti‐VEGFcataract surgeryoutcomesretinal vein occlusions

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor AVEGFA protein, humanRanibizumabGlucocorticoids

Autor:innen und Institutionen

  • Eye Clinic, Department of Biomedical and Clinical Science "Luigi Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy.
  • Discipline of Ophthalmology, Sydney Medical School, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia.
  • Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Mater Private Hospital, Dublin, Ireland.
  • Department of Ophthalmology, Isala, Zwolle, The Netherlands.
  • Department of Ophthalmology, University Hospital-St. Michael's Hospital, Bratislava, Slovakia.

ORCID-Profile: Alessandro Invernizzi, Matteo Airaldi, Mariano Cozzi, Vuong Nguyen, Adrian Hunt

Förderung

  • Royal Australian and New Zealand College of Ophthalmologists Eye Foundation
  • National Health and Medical Research Council
  • Unrestricted educational grants from Bayer (Leverkusen, Germany) and Novartis (Basel, Switzerland)

Zitieren

APA

Invernizzi, A., Airaldi, M., Cozzi, M., Nguyen, V., Hashimoto, Y., Barthelmes, D., O'Toole, L., Ponsioen, T. L., Kusenda, P., Lavid, F. J., Jaross, N., Gillies, M., & Hunt, A. (2025). Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14468

Vancouver

Invernizzi A, Airaldi M, Cozzi M, Nguyen V, Hashimoto Y, Barthelmes D, et al. Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion. Clinical & Experimental Ophthalmology. 2025. doi:10.1111/ceo.14468

BibTeX
@article{Invernizzi2025,
  author = {Invernizzi, Alessandro and Airaldi, Matteo and Cozzi, Mariano and Nguyen, Vuong and Hashimoto, Yohei and Barthelmes, Daniel and O'Toole, Louise and Ponsioen, Theodorus Leonardus and Kusenda, Pavol and Lavid, Francisco Javier and Jaross, Nandor and Gillies, Mark and Hunt, Adrian},
  title = {Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2025},
  doi = {10.1111/ceo.14468}
}
Kostenlos starten →